Here are some recent news (Sep. 06) on how to treat breast cancer:



Trials and research on how to treat the desease are not limited to North America. A University of Edinburgh scientist has evolved new procedures to analyze the affecting of radiation therapy after breast cancer surgery. New procedures can help doctors determine who would benefit from receiving radiation therapy as a follow-up to surgery. These new techniques will require doctors to check tissue samples from breast cancer surgeries to decide who should receive also radiation therapy.

A new test to be conducted internationally will track 3700 women to observe the benefits of radiation therapy in women who has a medium risk of recurrence. The study will also follow this group of women to discover if there is a considerable risk of core damage for those who have undergone announcement therapy. In short, it is important to determine if radiation therapy has any significant impact on the recurrence of cancer in low risk cancer patients.

The innovative trial will seek to identify a molecular signature in breast cancer that may help to decide if radiation therapy is necessary to prevent recurrence. Tissue from breast cancer surgeries will be used for extensive study in the future. Scientists are concerned about the long-term effect on the heart from issue and chemotherapy. The protein brain natriuretic peptide will also be researched to see if it is a premature sign of cardiac damage. Electrocardiography and echocardiography will also be used to identify any untimely signs of cardiac trouble.

This striving study would also like to look into the quality of life of breast cancer survivors. They will look at the impact of issue and chemotherapy, breast reconstruction and other quality of life areas. It will include women from all over the world. More than 120 breast cancer centers around the world have already signed up to take part in this project.

The study could have an impact on the cost of breast cancer treatment. If it can be determined if radiation therapy will not increase survival rates of those patients who are low risk, it could save the medical community and patients thousands of dollars. It's important to remember that, the health and survival of patients are the main concern of any trial or research carried on throughout the world.

The research may decide if women who were considered low-risk for recurrence of breast cancer would benefit from radiation therapy.

This new international trial is being sponsored and funded by the University of Edinburgh and Lothian Health Board as well as the United Kingdom Medical Research Council. The European Organization for Research on Treatment of Cancer and Breast International Group will coordinate the efforts of the trials around the globe.